Gary Titus

2016

In 2016, Gary Titus earned a total compensation of $402.4K as Former Chief Financial Officer at UroGen Pharma Ltd..

Compensation breakdown

Option Awards$87,847
Salary$314,053
Other$452
Total$402,353

Titus received $314.1K in salary, accounting for 78% of the total pay in 2016.

Titus also received $87.8K in option awards and $452 in other compensation.

Rankings

In 2016, Gary Titus' compensation ranked 11,901st out of 14,075 executives tracked by ExecPay. In other words, Titus earned more than 15.4% of executives.

ClassificationRankingPercentile
All
11,901
out of 14,075
15th
Division
Manufacturing
4,665
out of 5,486
15th
Major group
Chemicals And Allied Products
1,669
out of 1,900
12th
Industry group
Drugs
1,354
out of 1,543
12th
Industry
Pharmaceutical Preparations
1,043
out of 1,173
11th
Source: SEC filing on April 26, 2019.

Titus' colleagues

We found three more compensation records of executives who worked with Gary Titus at UroGen Pharma Ltd. in 2016.

2016

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

2016

Gil Hakim

UroGen Pharma Ltd.

Former President

2016

Ron Bentsur

UroGen Pharma Ltd.

Chief Executive Officer

News

You may also like